New oral hormone drug for prostate cancer
The Food and Drug Administration has approved the use of a new oral hormone therapy drug, Relugolix, for treating advanced prostate cancer in men.Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Cancer | Cancer & Oncology | Endocrinology | Food and Drug Administration (FDA) | Hormonal Therapy | Hormones | Oral Cancer | Prostate Cancer